Hereditary breast cancer: Risk assessment of patients with a family history of breast cancer

Canadian Family Physician

Volumn 45, Issue JAN., 1999, Pages 104-112

  Warner, Ellen ^a   Heisey, Ruth E ^b   Goel, Vivek ^b   Carroll, June C ^b   McCready, David R ^b  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALGORITHM; BREAST TUMOR; FEMALE; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; HUMAN; METHODOLOGY; MIDDLE AGED; REVIEW; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; ALGORITHMS; BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS;

EID: 0032600899     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Bryant HE, Brasher PMA. Risks and probabilities of breast cancer, short term versus lifetime probabilities. Can Med Assoc J 1994;150:211-6.
2. Ontario Cancer Treatment and Research Foundation. Cancer in Ontario 1994-1995. Toronto, Ont: Ontario Cancer Treatment and Research Foundation; 1995. p. 5.
3. Hoskins KF, Stopfer JE, Calzone KA, Merajver SD, Rebbeck TR, Garber JE, et al. Assessment and counselling for women with a family history of breast cancer - a guide for clinicians. JAMA 1995;273:577-85.
4. Yang Q, Khoury MJ, Rodriguez C, Calle EE, Tatham LM, Flanders WD. Family history score as a predictor of breast cancer mortality: prospective data from the cancer prevention study II, United States, 1982-1991. Am J Epidemiol 1998;147:652-9.
5. Morrow M. Identification and management of the woman at increased risk for breast cancer development. Breast Cancer Res Treat 1994;31:53-60.
6. Henderson IC. Risk factors for breast cancer development. Cancer 1993;71:2127-40.
7. Goss PE, Sierra S. Current perspectives on radiation-induced breast cancer. J Clin Oncol 1998;16:33347.
8. Warner E, Lockwood G, Tritchler D, Boyd NF. The risk of breast cancer associated with mammographic parenchymal patterns: a meta-analysis of the published literature to examine the effect of method of classification. Cancer Detect Prev 1992;16:67-72.
9. Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ. Automated analysis of mammographic densities. Phys Med Biol 1996;41:909-23.
10. Simpson ER, Mendelson CR. The role of adipose tissue in estrogen biosynthesis in the human. In: Frisch RE, editor. Adipose tissue and reproduction. New York, NY: Krager Publishing Co; 1990.
11. Schapira DV, Clark RA, Wolff PA, Jarrett AR, Kumar HB, Aziz NN. Visceral obesity and breast cancer risk. Cancer 1994;74:632-9.
12. Colditz GA. Relationship between estrogen levels, use of hormone replacement therapy and breast cancer. J Natl Cancer Inst 1998;90:814-23.
13. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiologic studies of 52 702 women with breast cancer and 108 411 without breast cancer. Lancet 1997;350:1047-59.
14. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiologic studies. Lancet 1996;347:1713-27.
15. Thun MJ, Peto R, Lopez AD, Monaco JH, Henley J, Heath CW, et al. Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med 1997;337:1705-14.
16. Smith-Warner SA, Spiegelman D, Yaun S-S, van den Brandt PA, Folsom AR, Goldbohm A Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA 1998;279:535-10.
17. Wynder EL, Cohen LA, Muscat JE, Winters B, Dwyer JT, Blackburn G, et al. Breast cancer weighing the evidence for a promoting role of dietary fat. J Natl Cancer Inst 1997;89:766-75.
18. Hunter DJ, Spiegelman D, Adam H-O, Beeson L, van den Brandt PA, Folsom AR, et al. Cohort studies of fat intake and the risk of breast cancer a pooled analysis. N Engl J Med 1996;334:356-61.
19. Boyd NF, Greenberg C, Lockwood G, Little L, Martin L, Byng J, et al. Effects of two years of a low-fat, high carbohydrate diet on radiological features of the breast. Results from a randomized trial. J Natl Cancer Inst 1997;89:488-96.
20. Franceschi S, LaVecchia C, Rosso A, Negri E, Favero A, Decarli A. Low risk diet for breast cancer in Italy. Cancer Epidemiol Biomark Prev 1997;6:875-9.
21. Longnecker MP, Newcomb PA, Mittendorf R, Greenberg R, Willett SC. Intake of carrots, spinach and supplements containing vitamin A in relation to breast cancer risk. Cancer Epidemiol Biomark Prev 1997;6:887-92.
22. Thune I, Brenn T, Lund E, Gaard M. Physical activity and the risk of breast cancer. N Engl J Med 1997;336:1269-75.
23. Palmer JR, Rossenberg L. Cigarette smoking and the risk of breast cancer. Epidemiol Rev 1993;15:145-56.
24. Michels KB, Willett WC, Rosner BA, Manson JE, Hunter PJ, Graham AC, et al. Prospective assessment of breastfeeding and breast cancer incidence among 89 887 women. Lancet 1996;347:431-6.
25. Adam H-O, Lipworth L, Titus-Ernstoff L, Hsieh CC, Hanberg A, Ahlborg U, et al. Organochlorine compounds and estrogen-related cancers in women. Cancer Cause Control 1995;6:551-66.
26. Hunter DJ, Hankinson SE, Laden F, Colditz GA, Manson JE, Willett WC, et al. Plasma organochlorine levels and the risk of breast cancer. N Engl J Med 1997;337:1253-8.
27. Narod SA. Hereditary breast cancer syndromes. Cancer 1997;80:537-42.
28. Blackwood MA, Weber BL. BRCA1 and BRCA2: from molecular genetics to clinical medicine. J Clin Oncol 1998;16:1969-77.
29. Madigan MP, Ziegler RG, Benichou J, et al. Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst 1995;87:1681-5.
30. Costanza MC, Foster RS Jr. Relationship between breast self-examination and death from breast cancer by age groups. Cancer Detect Prev 1984;7:103-8.
31. Hill D, White V, Jolley D, Mapperson K. Self examination of the breast: is it beneficial? Meta-analysis of studies investigating breast self examination and extent of disease in patients with breast cancer. BMJ 1988;297:271-5.
32. Harvey BJ, Miller AB, Baines CJ, Corey PN. Effect of breast self-examination techniques on the risk of death from breast cancer. Can Med Assoc J 1997;157:1205-12.
33. Semiglazov VF, Moiseyenko VM, Bavli JL, Migmanova NSH, Seleznyov NK, Popova RT, et al. The role of breast self-examination in early breast cancer detection (results of the 5-year USSR/WHO randomized study in Leningrad). Eur J Epidemiol 1992;8:498-502.
34. Thomas HDB, Gao DL, Self SG, Allison CJ, Tao Y, Mahloch J, et al. Randomized trial of breast self-examination in Shanghai: methodology and preliminary results. J Natl Cancer Inst 1997;89:355-65.
35. Morrison BJ. The Canadian Task Force on the Periodic Health Examination. Ottawa, Ont: Health Canada; 1994.
36. Cady B, Steele GD Jr, Morrow M, Gardner B, Smith BL, Lee NC, et al. Evaluation of common breast problems: guidance for primary care providers. CA Cancer J Clin 1998;48:4-63.
37. Newcomb PA, Weiss NS, Storer BE, Scholes D, Young BE, Voigt LF. Breast self-examination in relation to the occurrence of breast cancer. J Natl Cancer Inst 1991;83:260-5.
38. Fletcher SW, Black W, Harris R, Rimer BK, Shapiro S. Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst 1993;85:1644-56.
39. Royal Australian College of General Practitioners. Current best advice about familial aspects of breast cancer: a guide for general practitioners. Forest Lodge, NSW, Australia: Royal Australian College of General Practitioners; 1996.
40. Roberts MM, Alexander FE, Anderson TJ, Chetty U, Donnan FT, Forrest P, et al. Edinburgh trial of screening for breast cancer mortality at seven years. Lancet 1990;335:241-6.
41. Shapiro S. Health Insurance Plan of Greater New York. Periodic screening for breast cancer: the Health Insurance Plan project and its sequelae, 1963-1986. Baltimore, Md: Johns Hopkins University Press; 1988.
42. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study. 2. Breast cancer detection and death rates among women aged 50 to 59 years. Can Med Assoc J 1992;147:1477-88.
43. Sellers TA, Mink PJ, Cerhan JR, Zheng W, Anderson KE, Kushi LH, et al. The role of hormone replacement therapy in the risk for breast cancer and total mortality in women with a family history of breast cancer. Ann Intern Med 1997;127:973-80.
44. National Institutes of Health. NIH Consensus Development Conference statement. Breast screening for women ages 40-49. J Natl Cancer Inst 1997;89:1015-26.
45. Fletcher SW, Harris R. Breast cancer screening among women in their forties: an overview of the issues. J Natl Cancer Inst Monogr 1997;22:5-9.
46. Tabar L, Fagerberg G, Chen H-H, Duffy SW, Smart CR, Gad A, et al. Efficacy of breast cancer screening by age. Cancer 1995;75:2507-17.
47. Chart PL, Franssen E. Management of women at increased risk for breast cancer, preliminary results from a new program. Can Med Assoc J 1997;157:1235-42.
48. Stefanuk ME, Wilcox P. Breast self examination among women at increased risk: assessment of proficiency. Cancer Prev 1990;1:79-83.